mtmt
Magyar Tudományos Művek Tára
XML
JSON
Átlépés a keresőbe
In English
NeuroPsychopharmacotherapy
Riederer, P. [szerk.]
;
Laux, G. [szerk.]
;
Nagatsu, T. [szerk.]
;
Le, W. [szerk.]
;
Riederer, C. [szerk.]
;
Bitter, I [Bitter, István (Elmekórtan), szerk.] Pszichiátriai és Pszichoterápiás Klinika (SE / AOK / K)
Angol nyelvű Szakkönyv (Könyv) Tudományos
Megjelent: Springer International Publishing, Cham, Svájc, 4725 p.
2022
Azonosítók
MTMT: 33936414
DOI:
10.1007/978-3-030-62059-2
ISBN:
9783030620585
Scopus:
85158981931
Fejezetek
Hampel L. et al. Neurobiological Principles: Neurotransmitters. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 3-23
Müller N.. Neurobiological Principles: Psycho-Neuro-Immuno-Endocrinology. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 25-63
Dodel R. et al. Pharmacoeconomics. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 101-234
Naoi M. et al. TCM Substances in Neuropsychopharmacotherapy: Basic Aspects with a Focus on Depression. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 415-449
Wang Y. et al. TCM Substances in Neuropsychopharmacotherapy. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 451-493
Foley P.. Psychopharmacology: A Brief Overview of Its History. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 621-660
Vrublevska J. et al. Neuropsychopharmacotherapy: Guidelines. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 823-853
Li J. et al. Neuropsychopharmacotherapy: Differential Dose Regimes in China. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 855-867
Laux G.. Antidepressants: Definition, Classification, Guidelines. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 1101-1108
Efinger V. et al. Antidepressants: Pharmacology and Biochemistry. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 1109-1134
Corponi F. et al. Antidepressants: Indications, Contraindications, Interactions, and Side Effects. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 1135-1172
Brandt L. et al. Antidepressants: Course and Duration of Therapy, Withdrawal Syndromes, and Resistance to Therapy. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 1173-1191
Meyer J.H. et al. Monoamine Oxidase Inhibitors in Depressive Disorders. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 1347-1379
Schoretsanitis G. et al. Mood Stabilizers: Course and Duration of Therapy, Withdrawal Syndromes, and Resistance to Therapy. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 1469-1491
Gfesser J. et al. Guidelines on Mood Stabilizers. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 1639-1689
Kumbier E.. History of Antipsychotics. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 1731-1744
Morimoto Y. et al. Low-Potency Antipsychotics: Levomepromazine, Melperon, and Pipamperone. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 1783-1801
Schönknecht P.. Cariprazine in the Treatment of Psychosis. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 1953-1962
Stephens D.N.. Tranquilizers/Anxiolytics: Pharmacology and Biochemistry of Anxiolytic Drugs Acting via GABAergic Mechanisms. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 2053-2070
Grunze H.. Tranquilizer/Anxiolytics: Gabapentin. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 2099-2113
Herberger S. et al. Somnologics: Medicines for the Treatment of Sleep Disorders. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 2379-2417
Coghill D.. Psychostimulants: Primary and Secondary Indications. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 2451-2463
Hironaka N.. Pharmacology of Alcohol and Alcohol Use Disorder. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 2505-2524
Müller T. et al. Memantine for Treatment of Dementia. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 2723-2731
Tanaka Masaru et al. Novel Pharmaceutical Approaches in Dementia. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 2803-2820
Löscher W.. Anti-convulsant Agents: Pharmacology and Biochemistry. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 3413-3439
Bast T. et al. Anti-convulsant Agents: Potassium Bromide. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 3529-3535
Datta A.N. et al. Rational Antiepileptic Treatment in Childhood. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 3851-3875
Elger C.E. et al. Guidelines on Anti-convulsant Agents. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 3877-3886
Messer T. et al. Neuropsychopharmacotherapy: Emergency Psychiatry. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 3889-3933
Walitza S. et al. Neuropsychopharmacotherapy in Children and Adolescents. (2022) Megjelent: NeuroPsychopharmacotherapy pp. 4383-4398
Hivatkozás stílusok:
IEEE
ACM
APA
Chicago
Harvard
CSL
Másolás
Nyomtatás
2025-03-30 09:18
×
Lista exportálása irodalomjegyzékként
Hivatkozás stílusok:
IEEE
ACM
APA
Chicago
Harvard
Nyomtatás
Másolás
